Editorial Board
Haibo Xu Master of Medicine; Doctor of Philosophy (Guangzhou University of Chinese Medicine); Bachelor of Medicine (Southwest Medical University)
Professor, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan · China
Editorial leadership for International Journal of Complementary Medicine ISSN 3070-3360
Research interests
- Pathogenesis Of Gastrointestinal Cancer
- Hepatitis
- Hypertension
- And The Therapeutic Intervention In These Diseases With Traditional Chinese Medicine
- Along With The Delineation Of The Underlying Mechanisms For Chinese Herbal Effects
Biography
- Dr. Haibo Xu is a professor in the department of pharmacology, school of pharmacy, at the Chengdu University of Traditional Chinese Medicine (TCM), Sichuan, China.
- He got a bachelor's degree in medicine at the Southwest Medical University in China in 1997, a master's degree in pharmacology at the Guangzhou University of TCM in 2000, and a PhD in molecular pharmacology at the Guangzhou University of TCM in 2003, followed by his 6-month lectureship in the institute of gastroenterology, Guangzhou University of TCM, Guangdong, China.
- From March 2004 to February 2007, Dr. Xu was a postdoctoral research fellow in cancer biology in the department of surgery, centre for cancer research and cell biology, Queen’s University Belfast, UK, followed by another over 3-year research on hypertension in the school of physiology and pharmacology in the University of Bristol, UK.
- Dr. Xu has been holding several research grants as a principle investigator in China, with 40 published papers and 6 oral presentations in international conferences.
- He was awarded the European Investigators’ Travel Grant by the 19th European meeting on hypertension in Milan, organized by the European Society of Hypertension in 2009.
- He also received 4 travel grants from British Heart Foundation, Physiological Society of UK and the Cancer Recognised Research Group of Northen Ireland.
Selected publications
- Ursolic Acid Suppresses Colorectal Cancer by Down-Regulation of Wnt/β-Catenin Signaling Pathway Activity 2023 cited 77×
- Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis 2024 cited 67×
- Ursolic acid inhibits the activation of smoothened‐independent non‐canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade 2022 cited 14×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCO for your work?
This journal is guided by Haibo Xu (Professor, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.